Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma - Quiz - MDSpire

Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma

  • By

  • Hongan Fei

  • Xichao Wen

  • Wensong Wu

  • HaiPeng Liu

  • Haipeng Xie

  • Yan Wang

  • Kebin Zheng

  • Zhaomu Zeng

  • Zetong Bai

  • June 15, 2026

  • 0 min

Share

Original Source(s)

Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma

  • by Hongan Fei, Xichao Wen, Wensong Wu, HaiPeng Liu, Haipeng Xie, Yan Wang, Kebin Zheng, Zhaomu Zeng, Zetong Bai

  • June 15, 2026

Related Content

Postoperative anastomotic leakage after colon cancer surgery may reduce long-term survival

The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study

Case Report: KIF5B-ALK–rearranged renal cell carcinoma